Vancomycin Minimum Inhibitory Concentration and Outcome in Patients With Staphylococcus aureus Bacteremia: Pearl or Pellet?
Published 2011 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Vancomycin Minimum Inhibitory Concentration and Outcome in Patients With Staphylococcus aureus Bacteremia: Pearl or Pellet?
Authors
Keywords
-
Journal
JOURNAL OF INFECTIOUS DISEASES
Volume 204, Issue 3, Pages 329-331
Publisher
Oxford University Press (OUP)
Online
2011-07-09
DOI
10.1093/infdis/jir275
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Vancomycin: We Can't Get There From Here
- (2011) N. Patel et al. CLINICAL INFECTIOUS DISEASES
- Clinical Practice Guidelines by the Infectious Diseases Society of America for the Treatment of Methicillin-Resistant Staphylococcus aureus Infections in Adults and Children
- (2011) Catherine Liu et al. CLINICAL INFECTIOUS DISEASES
- Impact of Vancomycin Exposure on Outcomes in Patients With Methicillin-Resistant Staphylococcus aureus Bacteremia: Support for Consensus Guidelines Suggested Targets
- (2011) R. Kullar et al. CLINICAL INFECTIOUS DISEASES
- Relationship between the MIC of vancomycin and clinical outcome in patients with MRSA nosocomial pneumonia
- (2011) Eun Young Choi et al. INTENSIVE CARE MEDICINE
- Antibiotic Choice May Not Explain Poorer Outcomes in Patients With Staphylococcus aureus Bacteremia and High Vancomycin Minimum Inhibitory Concentrations
- (2011) Natasha E. Holmes et al. JOURNAL OF INFECTIOUS DISEASES
- Nosocomial methicillin-resistant Staphylococcus aureus (MRSA) bacteremia in Taiwan: Mortality analyses and the impact of vancomycin, MIC = 2 mg/L, by the broth microdilution method
- (2010) Jiun-Ling Wang et al. BMC INFECTIOUS DISEASES
- Relationship of Vancomycin Minimum Inhibitory Concentration to Mortality in Patients With Methicillin-Resistant Staphylococcus aureus Hospital-Acquired, Ventilator-Associated, or Health-care-Associated Pneumonia
- (2010) Nadia Z. Haque et al. CHEST
- Reduced Vancomycin Susceptibility in Staphylococcus aureus, Including Vancomycin-Intermediate and Heterogeneous Vancomycin-Intermediate Strains: Resistance Mechanisms, Laboratory Detection, and Clinical Implications
- (2010) B. P. Howden et al. CLINICAL MICROBIOLOGY REVIEWS
- Predictors of persistent methicillin-resistant Staphylococcus aureus bacteraemia in patients treated with vancomycin
- (2010) Y. K. Yoon et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Outcomes with daptomycin in the treatment of Staphylococcus aureus infections with a range of vancomycin MICs
- (2010) J. A. Crompton et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Paradoxical Relationship between the Clinical Outcome ofStaphylococcus aureusBacteremia and the Minimum Inhibitory Concentration of Vancomycin
- (2009) James Price et al. CLINICAL INFECTIOUS DISEASES
- Vancomycin Therapeutic Guidelines: A Summary of Consensus Recommendations from the Infectious Diseases Society of America, the American Society of Health‐System Pharmacists, and the Society of Infectious Diseases Pharmacists
- (2009) Michael J. Rybak et al. CLINICAL INFECTIOUS DISEASES
- Vancomycin MIC plus Heteroresistance and Outcome of Methicillin-Resistant Staphylococcus aureus Bacteremia: Trends over 11 Years
- (2009) A. C. Musta et al. JOURNAL OF CLINICAL MICROBIOLOGY
- Relationship between Vancomycin MIC and Failure among Patients with Methicillin-Resistant Staphylococcus aureus Bacteremia Treated with Vancomycin
- (2008) T. P. Lodise et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Influence of Vancomycin Minimum Inhibitory Concentration on the Treatment of Methicillin-Resistant Staphylococcus aureus Bacteremia
- (2007) A. Soriano et al. CLINICAL INFECTIOUS DISEASES
Become a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get StartedAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started